Maxwell
Miner
Senior Researcher, Turku PET Centre
Preclinical Imaging Department Project Manager, PhD
Contact
Links
Publications
Single-cell to pre-clinical evaluation of Trem2, Folr2, and Slc7a7 as macrophage-associated biomarkers for atherosclerosis (2025)
Cardiovascular Research
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Rapid cleavage of 6-[18F]fluoronicotinic acid prosthetic group governs BT12 glioblastoma xenograft uptake: implications for radiolabeling design of biomolecules (2025)
EJNMMI Radiopharmacy and Chemistry
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Comparing Two Folate Receptor β-Targeted Tracers in a Rat Model of Experimental Autoimmune Myocarditis (2025)
ACS pharmacology & translational science
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Evaluation of 18F FOL a PET tracer targeting folate receptor beta in a rat model of myocardial infarction (2024)
European Heart Journal
(Abstrakti)
New autoradiography image analysis tool combining overlain microscopy and histology in Carimas multimodal DICOM image analysis software (2024)
Annual Congress of the European Association of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging
(Abstrakti)
High folate receptor expression in gliomas can be detected in vivo using folate-based positron emission tomography with high tumor-to-brain uptake ratio divulging potential future targeting possibilities (2023)
Frontiers in Immunology
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Emerging radiopharmaceuticals for PET-imaging gliomas. A multi-: radiopharmaceutical, camera, modality, model, and modelling assessment (2023)
(G5 Artikkeliväitöskirja)Targetting folate receptor-β expressing macrophages by 18F-labelled folate PET radiotracer in rat model of myocardial infarction (2022)
Annual Congress of the European association of nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging
(Vertaisarvioimaton konferenssijulkaisu (B3))
Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-F-18-Fluoroglutamine (2022)
Frontiers in Immunology
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Preclinical Evaluation of a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, 89Zr-Desferrioxamine-Bexmarilimab, in a Rabbit Model of Renal Fibrosis (2022)
Journal of Nuclear Medicine
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )